MT-3001 (Macrophage Therapeutics)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameMT-3001 (Macrophage Therapeutics)
Drug Alias NameMT-3001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMacrophages inhibitors
TargetsUpdating
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMacrophage Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMacrophage Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A